CSI Market
Sign In | Register

Vsee Health Inc (VSEE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access VSEE Annual Cash Flow →
Looking at cash flow data from Vsee Health Inc through Jun 30 2025 provides insight into Jun 30 2026's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-4.34
Depreciation & amortization1.29
Amortization of Other Assets1.85
Increase (Decrease) in Deferred Revenue0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.87
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.54
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Interest Earned On Investments Held In Trust Accounts-
Change In Fair Value Of Pipe Forward Contract Derivative-
Financing Costs Included In Note-
Warrants Issued As Financing Cost In Note-
Investment Income Interest-
Gian Loss On Issuance Of Financial Instruments-
Fair Value Adjustment Of Financial Instruments-
Amortization Of Right Of Use Asset0.00
Increase Decrease In Operating Lease Liability0.00
Receivables Credit Loss Expense Reversal-
Gain On Forgiveness Of Debt-
Stock Issued For Conversion Of Underwriter Fee-
Stock Issued For Debt Settlement-
Shares Issued As Part Of Stock Grants To Vendors-
Loss On Issuance Of Financial Instrument-
Gain Loss On Issuance Of Financial Instruments-
Increase Decrease Change In Fair Value Of Financial Instruments-0.14
Gain On Extinguishment Of E L O C-
Gain Loss On Termination Of Lease-
Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal0.36
Increase Decrease In Encompass Purchase Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.01
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.22
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.12
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.51
Discontinued operations-2.69
Net Cash flow from Operating Activities-3.63
Investing Activities
Capital Expenditures-0.10
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Long-term Investments-0.10
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.10
Discontinued operations-0.03
Net Cash Flow from Investing Activities-0.13
Financing Activities
Short-term debt Net-0.35
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.78
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-0.05
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.34
Proceeds From Related Party As Advances-
Proceeds From M2b Note-
Repayment On Factoring Payable-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents5.27
Finance Lease Principal Payments-0.59
Proceeds From Share Repurchase Liability-
Proceeds From Reverse Recapitalization-
Repayment On Extension Note-
Repayment On Additional Bridge Financing-
Repayment On Encompass Purchase Liability-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.84
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-3.73
Total Cash Flow-4.60
4 historic quarters locked

Sign in to unlock the full Vsee Health Inc cash flow history.

Sign In Create Free Account

About Vsee Health Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001185185-26-003549

Figures are derived from filed reports and may be restated. Historical data is subject to revision.